16:29 EDT Anika Therapeutics sees FY24 revenue $168M-$173M, consensus $170.27M
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ANIK:
- Anika Therapeutics Announces New CFO and Executive Changes
- Anika Announces CFO Transition
- ANIK Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Medicare Administrators looking to ‘drastically shake up’ wound care, says BTIG